xista science ventures

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. The company specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses responsible for colds and flu infections. Its primary product, a targeted therapy utilizing 2-deoxyglucose, disrupts the metabolic processes of host cells, thereby hindering viral replication both in vitro and in vivo, particularly against rhinovirus. By employing a novel host cell-based strategy, G.ST Antivirals aims to create broad-spectrum antiviral treatments that address unmet medical needs in the management of respiratory tract infections.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.

Sarcura GmbH is an Austrian deep-tech startup founded in 2019, focused on developing a machine platform for the large-scale industrial manufacturing of personalized cell therapies aimed at treating cancer. The company leverages innovative semiconductor technology and microfluidic processing to achieve real-time control and manipulation at the cellular level. This approach facilitates a fully automated and modular manufacturing system, which enhances the efficiency and safety of producing advanced cell therapies tailored to individual patient needs. Sarcura's platform represents a significant shift in manufacturing paradigms, contributing to more accessible and cost-effective treatment options for patients. The company operates from Hinterstoder, Austria.

Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.

Ribbon Biolabs GmbH, founded in 2018 and based in Vienna, Austria, specializes in the synthesis of long deoxyribonucleic acid (DNA) molecules. The company employs innovative techniques to produce DNA of unprecedented lengths, setting new standards in molecular biology. Its services cater to the diverse needs of synthetic biology, supporting researchers and companies in various applications, including genome construction, high-throughput library creation, and the development of DNA-based products and nanotechnology devices. By enabling the synthesis of long DNA sequences without economic or time constraints, Ribbon Biolabs aims to advance the next wave of biotechnologies and facilitate cutting-edge research in genetic solutions.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced liquid-crystal display (LCD) backlighting solutions. The company utilizes glass-based waveguides and laser-powered photonic integrated circuits to create a groundbreaking quantum light chip that enhances display technology. This innovation replaces traditional backlight units with dedicated light sources for each sub-pixel, significantly improving energy efficiency, brightness, contrast ratio, and color rendering. VitreaLab's technology is designed to deliver high-quality illumination for 3D, virtual reality (VR), and augmented reality (AR) applications, offering unparalleled brightness and color quality while consuming less energy than competing solutions.

contextflow GmbH is a company based in Vienna, Austria, specializing in machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, it has developed a 3D image-based search engine that enables radiologists to quickly identify regions of interest in medical images, particularly in lung CT scans. This technology allows for the rapid retrieval of similar cases and relevant clinical information, enhancing decision-making processes in diagnostics. contextflow's software is designed to integrate seamlessly with existing radiology workflows, thereby improving efficiency and patient care. The company has established strategic partnerships with various organizations, including radiology centers and health associations, and is currently conducting trials of its software with multiple partners. Recognized for its innovation, contextflow has received several awards and was selected to participate in an accelerator program aimed at advancing health technology.

Sarcura GmbH is an Austrian deep-tech startup founded in 2019, focused on developing a machine platform for the large-scale industrial manufacturing of personalized cell therapies aimed at treating cancer. The company leverages innovative semiconductor technology and microfluidic processing to achieve real-time control and manipulation at the cellular level. This approach facilitates a fully automated and modular manufacturing system, which enhances the efficiency and safety of producing advanced cell therapies tailored to individual patient needs. Sarcura's platform represents a significant shift in manufacturing paradigms, contributing to more accessible and cost-effective treatment options for patients. The company operates from Hinterstoder, Austria.

Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. The company specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses responsible for colds and flu infections. Its primary product, a targeted therapy utilizing 2-deoxyglucose, disrupts the metabolic processes of host cells, thereby hindering viral replication both in vitro and in vivo, particularly against rhinovirus. By employing a novel host cell-based strategy, G.ST Antivirals aims to create broad-spectrum antiviral treatments that address unmet medical needs in the management of respiratory tract infections.

VitreaLab GmbH, founded in 2018 and based in Vienna, Austria, specializes in the development of advanced liquid-crystal display (LCD) backlighting solutions. The company utilizes glass-based waveguides and laser-powered photonic integrated circuits to create a groundbreaking quantum light chip that enhances display technology. This innovation replaces traditional backlight units with dedicated light sources for each sub-pixel, significantly improving energy efficiency, brightness, contrast ratio, and color rendering. VitreaLab's technology is designed to deliver high-quality illumination for 3D, virtual reality (VR), and augmented reality (AR) applications, offering unparalleled brightness and color quality while consuming less energy than competing solutions.

Ribbon Biolabs GmbH, founded in 2018 and based in Vienna, Austria, specializes in the synthesis of long deoxyribonucleic acid (DNA) molecules. The company employs innovative techniques to produce DNA of unprecedented lengths, setting new standards in molecular biology. Its services cater to the diverse needs of synthetic biology, supporting researchers and companies in various applications, including genome construction, high-throughput library creation, and the development of DNA-based products and nanotechnology devices. By enabling the synthesis of long DNA sequences without economic or time constraints, Ribbon Biolabs aims to advance the next wave of biotechnologies and facilitate cutting-edge research in genetic solutions.

Prewave GmbH is a technology company based in Vienna, Austria, that specializes in developing machine learning solutions for supply chain risk management. Founded in 2017, Prewave's platform utilizes advanced data analytics to analyze social media data, allowing businesses to monitor for potential supply chain anomalies. By predicting upcoming risk events, the platform helps companies enhance their logistics networks and identify sustainability challenges. Through its innovative approach, Prewave aims to provide organizations with insights that enable them to proactively address risks within their supply chains.

contextflow GmbH is a company based in Vienna, Austria, specializing in machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, it has developed a 3D image-based search engine that enables radiologists to quickly identify regions of interest in medical images, particularly in lung CT scans. This technology allows for the rapid retrieval of similar cases and relevant clinical information, enhancing decision-making processes in diagnostics. contextflow's software is designed to integrate seamlessly with existing radiology workflows, thereby improving efficiency and patient care. The company has established strategic partnerships with various organizations, including radiology centers and health associations, and is currently conducting trials of its software with multiple partners. Recognized for its innovation, contextflow has received several awards and was selected to participate in an accelerator program aimed at advancing health technology.